Bethel Family Clinic
Analysis
Bethel Family Clinic is a registered charity in United States, based in Bethel, AK. It received its IRS tax-exemption ruling in September 1983, 43 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending December 2023, Bethel Family Clinic reported income of $4.3m and spending of $4.0m, spending 91% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $4.4m to $4.3m (-0.3%), an average of -0.1% a year. The sharpest change came in the year to December 2023, when income dropped by 30%. Over the whole period it spent 102% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Bethel Family Clinic sits at the 78th percentile: it is larger than about 78% of them. Against every charity in United States with reported income it ranks in the 91st percentile, and in the 91st percentile within AK. Charities of a similar size with the same main cause include The Life Change Center ($4.3m), Northbay Health Advantage ($4.4m) and Recovery Cafe ($4.3m).
On its Form 990 for the period ending December 2023, revenue came from contributions and grants 55% and program service revenue 44% of the total. Compensation of current officers, directors and key employees was $204k (5.2% of expenses). Other salaries and wages came to $1.4m. At year end it held assets of $5.3m against liabilities of $1.1m, net assets of $4.2m. It reported 16 employees.
Income and spending
Where the income comes from
- Contributions & grants 55%
- Program services 44%
- Other 0.1%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| The Life Change Center | Sparks | $4.3m |
| Northbay Health Advantage | Fairfield | $4.4m |
| Recovery Cafe | Seattle | $4.3m |
| Drugs for Neglected Diseasesinitiative North America Inc | New York | $4.4m |